Literature DB >> 29940406

Predictive value of serum albumin levels on noradrenaline and fluid requirements in the first 24 h after admission to the Intensive Care Unit - A prospective observational study.

Dianne E C van Beek1, Marc H H Königs2, Yvette A M Kuijpers2, Iwan C C van der Horst3, Thomas W L Scheeren4.   

Abstract

PURPOSE: To determine the predictive value of serum albumin (SA) at admission to the intensive care unit (ICU) on the cumulative dose of noradrenaline, the fluids administered, the lactate level, and mortality during the first 24 h of ICU admission.
METHODS: A total of 100 ICU patients were included. The association between SA and the cumulative dose of noradrenaline was analyzed using logistic regression. For the total amount of fluids administered linear regression, for the lactate level and for 24 h mortality logistic regression was used. Age, gender, patient category, type of surgery, severe sepsis, lactate level, estimated glomerular filtration rate, c-reactive protein level, and the target mean arterial pressure were considered effect modifiers.
RESULTS: SA was significantly associated with the dose of noradrenaline (OR 0.92, 95% CI 0.84–0.99, p = 0.028), lower lactate levels (OR 1.14, 95% CI 1.00–1.30, p = 0.049), and with the amount of fluids administered (B -0.02, 95% CI −0.03/−0.00, p = 0.016), but not with mortality (OR 0.95, 95% CI 0.85–1.07, p = 0.41).
CONCLUSIONS: SA significantly predicts noradrenaline and fluid requirements as well as the change in lactate level during the first 24 h of ICU admission. Our observations have to be validated in another large cohort.

Entities:  

Keywords:  Albumin; Fluids; Intensive care; Noradrenaline; Outcome; Prediction

Mesh:

Substances:

Year:  2018        PMID: 29940406     DOI: 10.1016/j.jcrc.2018.06.011

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  2 in total

1.  U-shaped association between serum albumin and pediatric intensive care unit mortality in critically ill children.

Authors:  Xuepeng Zhang; Lifan Zhang; Canzheng Wei; Liwei Feng; Juqin Yang; Geng Zhang; Guoyan Lu; Xiying Gui; Yue Zhou; Kaiying Yang; Jiangyuan Zhou; Xinle Zhou; Ruoran Wang; Siyuan Chen; Yi Ji
Journal:  Front Nutr       Date:  2022-08-30

2.  Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.

Authors:  Imke H Bartelink; Pierre M Bet; Nicolas Widmer; Monia Guidi; Erik Duijvelaar; Bram Grob; Richard Honeywell; Amanda Evelo; Ivo P E Tielbeek; Sue D Snape; Henrike Hamer; Laurent A Decosterd; Harm Jan Bogaard; Jurjan Aman; Eleonora L Swart
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.